Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Forensic Science International
|
January 8, 2008
Designer drugs in herbal aphrodisiacs
Bastiaan J Venhuis, Leonore Blok-Tip, Dries de Kaste
Drug Testing and Analysis
|
October 15, 2013
A methamphetamine analog (N,α-diethyl-phenylethylamine) identified in a mainstream dietary supplement
Pieter A Cohen, John C Travis, Bastiaan J Venhuis
Drug Testing and Analysis
|
October 9, 2014
A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements
Pieter A Cohen, John C Travis, Bastiaan J Venhuis
Journal of Pharmaceutical and Biomedical Analysis
|
September 3, 2016
The quality of sildenafil active substance of illegal source
Peter H J Keizers, Andrea Wiegard, Bastiaan J Venhuis
Drug Testing and Analysis
|
October 13, 2015
Operation resistance: A snapshot of falsified antibiotics and biopharmaceutical injectables in Europe
Bastiaan J Venhuis, Peter H J Keizers, Rüdiger Klausmann, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
February 14, 2021
Current challenges in the detection and analysis of falsified medicines
Ingrid M E Bakker-'t Hart, Dana Ohana, Bastiaan J Venhuis
Clinical Toxicology (Philadelphia, Pa.)
|
March 23, 2021
Nine prohibited stimulants found in sports and weight loss supplements: deterenol, phenpromethamine (Vonedrine), oxilofrine, octodrine, beta-methylphenylethylamine (BMPEA), 1,3-dimethylamylamine (1,3-DMAA), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylbutylamine (1,3-DMBA) and higenamine
Pieter A Cohen, John C Travis, Céline Vanhee, et al.
Journal of Medicinal Chemistry
|
February 17, 2006
Extremely potent orally active benzo[g]quinoline analogue of the dopaminergic prodrug: 1-propyl-trans-2,3,4,4a,5,7,8,9,10,10a-decahydro-1H-benzo-[g]quinolin-6-one [corrected]
Danyang Liu, Håkan V Wikström, Durk Dijkstra, et al.
The Lancet. Oncology
|
April 4, 2018
Oncology drugs in the crosshairs of pharmaceutical crime
Bastiaan J Venhuis, Angela E Oostlander, Domenico Di Giorgio, et al.
Scandinavian Journal of Medicine & Science in Sports
|
October 31, 2019
Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids
Diederik L Smit, Olivier de Hon, Bastiaan J Venhuis, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Forensic Science International
|
January 8, 2008
Designer drugs in herbal aphrodisiacs
Bastiaan J Venhuis, Leonore Blok-Tip, Dries de Kaste
Drug Testing and Analysis
|
October 15, 2013
A methamphetamine analog (N,α-diethyl-phenylethylamine) identified in a mainstream dietary supplement
Pieter A Cohen, John C Travis, Bastiaan J Venhuis
Drug Testing and Analysis
|
October 9, 2014
A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements
Pieter A Cohen, John C Travis, Bastiaan J Venhuis
Journal of Pharmaceutical and Biomedical Analysis
|
September 3, 2016
The quality of sildenafil active substance of illegal source
Peter H J Keizers, Andrea Wiegard, Bastiaan J Venhuis
Drug Testing and Analysis
|
October 13, 2015
Operation resistance: A snapshot of falsified antibiotics and biopharmaceutical injectables in Europe
Bastiaan J Venhuis, Peter H J Keizers, Rüdiger Klausmann, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
February 14, 2021
Current challenges in the detection and analysis of falsified medicines
Ingrid M E Bakker-'t Hart, Dana Ohana, Bastiaan J Venhuis
Clinical Toxicology (Philadelphia, Pa.)
|
March 23, 2021
Nine prohibited stimulants found in sports and weight loss supplements: deterenol, phenpromethamine (Vonedrine), oxilofrine, octodrine, beta-methylphenylethylamine (BMPEA), 1,3-dimethylamylamine (1,3-DMAA), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylbutylamine (1,3-DMBA) and higenamine
Pieter A Cohen, John C Travis, Céline Vanhee, et al.
Journal of Medicinal Chemistry
|
February 17, 2006
Extremely potent orally active benzo[g]quinoline analogue of the dopaminergic prodrug: 1-propyl-trans-2,3,4,4a,5,7,8,9,10,10a-decahydro-1H-benzo-[g]quinolin-6-one [corrected]
Danyang Liu, Håkan V Wikström, Durk Dijkstra, et al.
The Lancet. Oncology
|
April 4, 2018
Oncology drugs in the crosshairs of pharmaceutical crime
Bastiaan J Venhuis, Angela E Oostlander, Domenico Di Giorgio, et al.
Scandinavian Journal of Medicine & Science in Sports
|
October 31, 2019
Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids
Diederik L Smit, Olivier de Hon, Bastiaan J Venhuis, et al.
Page
of 3